• Publications
  • Influence
Long-Term Controlled Clinical Trial of a New Anti-Inflammatory Drug, Diftalone, in Rheumatoid Arthritis
A long-term (two years) double-blind, comparative trial of diftalone (Aladione ®) 500 mg versus indomethacin 75 mg per day, in rheumatoid arthritis (thirty-two patients), has shown a similarExpand
  • 31
The therapy with cyclosporin A in rheumatoid arthritis.
Cyclosporin A (CyA) was administered in 6 cases of classical or definite, seropositive rheumatoid arthritis (RA), stages II or III, resistant to the antiinflammatory or nonsteroid therapy, orExpand
  • 1
The role of infections with Yersinia pseudotuberculosis and Yersinia enterocolitica in the pathogenesis of chronic inflammatory, rheumatic and collagen diseases.
From 50 cases of polyarthritis with febrile onset, 3 were found with serum positive Yersinia pseudotuberculosis (YPT) at a titer higher than 1/100. Reactive polyarthritis with gram-negative germsExpand
  • 3
Effect of long-term therapy with transfer factor in rheumatoid arthritis.
Specific immunotherapy with transfer factor (TF) was used in a chronic experiment in a group of 50 female patients with rheumatoid arthritis (RA) stage I-III. The patients were followed up for 24Expand
  • 5
A Controlled Clinical Trial of a New Anti-Inflammatory Drug, Diftalone, in Rheumatoid Arthritis
In a double-blind, randomized trial on thirty-two patients affected by classical or definite rheumatoid arthritis, we have tried the effectiveness and safety of500 mglday oral diftalone versus 75Expand
  • 2
Study of trace elements in patients with rheumatoid arthritis stage I-II, before and after treatment.
The study of the copper, zinc, iron and magnesium serum values in 35 patients with rheumatoid arthritis (RA) stage I-II, before and after therapy with indocin, gold salts and transfer factor showed aExpand
  • 1
[Further aspects of choledocholithiasis].
...
1
2
3
4
...